These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36637163)

  • 1. Circ-N4BP2L2 enhances mitochondrial function in non-small cell lung cancer cells through regulating the miR-135a-5p/ARL5B axis.
    Shi H; Ji Y; Zhang Y; Wang Y; Li W
    Environ Toxicol; 2023 Mar; 38(4):883-898. PubMed ID: 36637163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circular RNA circ_0003028 contributes to tumorigenesis by regulating GOT2 via miR-1298-5p in non-small cell lung cancer.
    Guan H; Sun C; Gu Y; Li J; Ji J; Zhu Y
    Bioengineered; 2021 Dec; 12(1):2326-2340. PubMed ID: 34077306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circ_PIP5K1A regulates cisplatin resistance and malignant progression in non-small cell lung cancer cells and xenograft murine model via depending on miR-493-5p/ROCK1 axis.
    Feng N; Guo Z; Wu X; Tian Y; Li Y; Geng Y; Yu Y
    Respir Res; 2021 Sep; 22(1):248. PubMed ID: 34537072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The circ-PITX1 promotes non-small cell lung cancer development via the miR-30e-5p/ITGA6 axis.
    Li W; Yang P; Zhong C; Shen X; Shi X; Li X
    Cell Cycle; 2022 Feb; 21(3):304-321. PubMed ID: 35007184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of circ_PLXND1 inhibits tumorigenesis of non-small cell lung carcinoma via miR-1287-5p/ERBB3 axis.
    Wu J; Liu C; Yu G
    Thorac Cancer; 2023 Jun; 14(17):1543-1555. PubMed ID: 37073425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circular non-coding RNA circ_0072088 serves as a ceRNA, targeting the miR-1225-5p/WT1 axis to regulate non-small cell lung cancer cell malignant behavior.
    Zhu X; Wan J; You X; Yang W; Zhao L
    Thorac Cancer; 2023 Jul; 14(20):1969-1979. PubMed ID: 37220935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circ_0014130 Participates in the Proliferation and Apoptosis of Nonsmall Cell Lung Cancer Cells via the miR-142-5p/IGF-1 Axis.
    Wang M; Shi J; Jiang H; Xu K; Huang Z
    Cancer Biother Radiopharm; 2020 Apr; 35(3):233-240. PubMed ID: 31916848
    [No Abstract]   [Full Text] [Related]  

  • 8. Circ_0074027 Contributes to Non-Small Cell Lung Cancer Progression by Upregulating
    Yu C; Ying J; Yu K; Shen W; Jiang M
    Cancer Biother Radiopharm; 2022 Mar; 37(2):73-83. PubMed ID: 32580576
    [No Abstract]   [Full Text] [Related]  

  • 9. Circ_0003998 Regulates the Progression and Docetaxel Sensitivity of DTX-Resistant Non-Small Cell Lung Cancer Cells by the miR-136-5p/CORO1C Axis.
    Zhang W; Song C; Ren X
    Technol Cancer Res Treat; 2021; 20():1533033821990040. PubMed ID: 33511909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circular RNA hsa_circ_0004396 acts as a sponge of miR-615-5p to promote non-small cell lung cancer progression and radioresistance through the upregulation of P21-Activated Kinase 1.
    Li D; Yan L; Zhang J; Gu F
    J Clin Lab Anal; 2022 Jun; 36(6):e24463. PubMed ID: 35500159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soy isoflavone genistein inhibits hsa_circ_0031250/miR-873-5p/FOXM1 axis to suppress non-small-cell lung cancer progression.
    Yu Y; Xing Y; Zhang Q; Zhang Q; Huang S; Li X; Gao C
    IUBMB Life; 2021 Jan; 73(1):92-107. PubMed ID: 33159503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. circ_0007385 served as competing endogenous RNA for miR-519d-3p to suppress malignant behaviors and cisplatin resistance of non-small cell lung cancer cells.
    Ye Y; Zhao L; Li Q; Xi C; Li Y; Li Z
    Thorac Cancer; 2020 Aug; 11(8):2196-2208. PubMed ID: 32602212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circular RNA hsa_circ_0014130 Inhibits Apoptosis in Non-Small Cell Lung Cancer by Sponging miR-136-5p and Upregulating BCL2.
    Geng Y; Bao Y; Zhang W; Deng L; Su D; Zheng H
    Mol Cancer Res; 2020 May; 18(5):748-756. PubMed ID: 32060230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hsa_circRNA_0017620 regulated cell progression of non-small-cell lung cancer via miR-520a-5p/KRT5 axis.
    Chen S; Hong K; Zhou L; Ran R; Huang J; Zheng Y; Xing M; Cai Y
    J Clin Lab Anal; 2022 Apr; 36(4):e24347. PubMed ID: 35302673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hsa_circ_0017639 regulates cisplatin resistance and tumor growth via acting as a miR-1296-5p molecular sponge and modulating sine oculis homeobox 1 expression in non-small cell lung cancer.
    Chang F; Li J; Sun Q; Wei S; Song Y
    Bioengineered; 2022 Apr; 13(4):8806-8822. PubMed ID: 35287543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hsa_circ_0069244 acts as the sponge of miR-346 to inhibit non-small cell lung cancer progression by regulating XPC expression.
    Shi J; Wang H; Feng W; Huang S; An J; Wang L; Jiang J
    Hum Cell; 2021 Sep; 34(5):1490-1503. PubMed ID: 34228324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomal circ_PIP5K1A regulates the progression of non-small cell lung cancer and cisplatin sensitivity by miR-101/ABCC1 axis.
    Shao N; Song L; Sun X
    Mol Cell Biochem; 2021 Jun; 476(6):2253-2267. PubMed ID: 33570734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circ_0076305 regulates cisplatin resistance of non-small cell lung cancer via positively modulating STAT3 by sponging miR-296-5p.
    Dong Y; Xu T; Zhong S; Wang B; Zhang H; Wang X; Wang P; Li G; Yang S
    Life Sci; 2019 Dec; 239():116984. PubMed ID: 31647948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circ_0000514 promotes the malignant biological behaviors of non-small cell lung cancer cells by modulating miR-330-5p and HMGA2.
    Jia L; Liu M; An L; Wang H; Wang X
    Pathol Res Pract; 2022 Jul; 235():153913. PubMed ID: 35552087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blocking circ_0010235 suppresses acquired paclitaxel resistance of non-small cell lung cancer by sponging miR-512-5p to modulate FAM83F expression.
    Li Y; Ma Z; Luo M; Liang R
    Anticancer Drugs; 2022 Nov; 33(10):1024-1034. PubMed ID: 36206095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.